Welcome to the Homepage of

PACT – Platform for Advanced Cellular Therapies

 

Save the date

PACT Summer School 2018

„Biomedicine: Stem Cells and Regeneration”

09 – 13 July 2018 in Vienna

 

 

PACT organizes its fourth Summer School from 09-13 July 2018 in Vienna.

 

This year’s summer school will focus on cell therapy for tissue regeneration and immune modulation. The program will include class lectures and hands on courses in the lab targeting different raw materials like the cryopreserved clinical grade transplantable cells and therapeutic extracellular vesicles. We will accumulate information about the isolation of such material, the demands and challenges of propagation and finally the analytical evaluation of the cells. In addition putative side effects including ‘instant blood-mediated inflammatory reaction’ (IBMIR) and the pro-thrombotic risk of extra-vascular cell therapeutics will be addressed. Throughout the course we will highlight the importance of entrepreneurial thinking, which is needed to transfer an academic result to a medical application for the benefit of patients. There will also be plenty of time for fruitful discussions with the lecturers and participants and several social events for networking.

 

  • Topics:
  • Adult and induced pluripotent stem cell therapies (Dirk Strunk and Martin Wolf, Paracelsus Medical University, Salzburg, Austria)
  • Regenerative Orthopedics (Tobias Winkler, Charité Universitätsmedizin Berlin, Germany)
  • Extracellular Vesicles: Bench to Bedside (Bernd Giebel, Universitätsklinikum Essen, Germany)
  • Thrombotic risk of cell therapies (Katharina Schallmoser and Michaela Öller, Paracelsus Medical University, Salzburg, Austria)
  • Hematopoietic stem cell therapies (Michael B. Fischer, Danube University Krems, Austria)
  • Primary cells as in vitro models in biomedicine (Regina Grillari, Evercyte GmbH, Vienna, Austria)
  • Entrepreneurial Science: From concept to patient (Mike Comer, Chairman PACT, Vienna, Austria)

 

 

Preliminary time schedule will be available here from end of April

 

School credits: 2 ECTS

Please note: If you intend to receive an official report for this course, you have to co-registrate at the BOKU until 30 April 2018.

 

Fee: 250 €

The fee includes tuition, and social events during the course. Accommodation and meals must be organized individually.

 

Course prerequisites:

Qualified master students as well as MScs, PhD/doctoral students and human or veterinarian medical doctors are invited to apply. We accept the application of postdocs.

 

Application:

Please complete the Application Form and send it to office@pact.ac.at.

 

Application deadline: 18 May 2018

Applications will undergo a selection procedure and applicants will be notified on or before the 28 May 2018 about their resulting admission to the Summer School.

 

The fee has to be transferred until 11 June 2018. Your registration will be confirmed as soon as we receive the payment.

 

Organizers: Dirk Strunk, Michael B. Fischer

 

Course language: English

 

Venue:

University of Natural Resources and Life Sciences, Vienna (BOKU)

Muthgasse 11, 1190 Vienna, Austria

 

Supported by:

Hochschulraumstrukturmittel Project: „Development of Further Synergies Between Medical Biotechnology, Molecular Cell Biology and Cellular Therapies“ with financial contribution from the Austrian Federal Ministry of Science, Research and Economy, the University of Natural Resources and Life Sciences,Vienna, the University of Veterinary Medicine, Vienna and the Institute of Science and Technology, Austria.

 

 

If you have any further questions please do not hesitate to contact us at office@pact.ac.at.

 

 

Recap EACTS – PACT Joint Symposium

„Regenerative Medicine: Taking the Science to the Patient“

30th November and 1st December 2017

Vienna, Austria

 

By the time you read this, we trust that you have returned safe and well to your work place with a motivation and determination to continue your work at least a little, in some aspect, inspired by our joint symposium.

 

The aim of scientific work in the field of regenerative medicine is to develop devices or novel cell based therapies and derived products that will serve to treat or cure disease-ridden patients. Indeed, to augment and exchange knowledge between groundbreaking fundamental research, the “clinic” and the health agencies that finally approve novel medical devices and novel drug therapies to society. With this in mind, EACTS and PACT joined forces to organize a meeting that brought together basic scientist, clinicians, regulatory affairs and service providers to discuss outlook and progress in regenerative medicine.

 

Especially in the cardiothoracic field which was the focus of this year’s symposium the “cell centric vision” is under heavy discussion after potential cell based therapies in myocardial infarction have not lived up to the expectations hypothesized by preclinical research. However, novel scientific developments like secretory products derived from cells with regenerative and/or cytoprotective capabilities can now be seen on the horizon of scientific endeavour.

 

At the Symposium, the excellent quality of the chairs, their session keynotes and speakers with your enthusiasm as participants contributed greatly to make this symposium not only successful but an exhilarating experience. At this point, we would like to thank our Sponsors again very much indeed, since without their support and loyalty such a Symposium would simply not occur. It was also very gratifying to note that so much of the “audience” was students to whom the future of our knowledge belongs and who can continue to develop their skills for patient benefit.

 

Undoubtedly, cell based therapies will come to the benefit of patients or indeed, cell derived “soups” will develop into “cocktails” or regimes for treatments that will contribute to relieve human and animal disease or suffering.

 

Finally, we would like to draw your attention to the Book of Abstracts that is available now and the Video Recordings of highlights of this Symposium that will be available by end of January 2018.

 

“What appears as the impossible is more likely to happen the more often it is attempted” let us continue to work together in “Taking the Science to the Patient”.

 

Michael Comer, Hendrik Jan Ankersmit, Beatrix Mayer-Reinprecht

 

We cordially welcome our new Institute Member

Center for Translational Medicine (CTM)

International Clinical Research Center 

St. Anne’s University Hospital Brno

 

St. Anne’s University Hospital Brno
International Clinical Research Center
Pekařská 53
656 91 Brno
Czech Republic

www.fnusa-icrc.org

 

The Center for Translational Medicine (CTM) is a highly interdisciplinary research platform in the International Clinical Research Center (FNUSA-ICRC), a European Union-funded project of the St. Anne’s University Hospital Brno (Czech Republic). The funds so far collected from EU were mostly used to build its own state-of-the-art translational medical research premises. The research center, currently hosts young promising researchers and students from all over the world (9 nationalities represented) and aims at unveiling the molecular mechanisms involved in the onset and progression of the diseases of aging. For this purpose, CTM adopts original and interdisciplinary approaches based on the use of smart materials, microfluidics systems, bioreactors, mechanically-assisted devices and multi-faceted molecular and cellular biology skills to investigate the molecular basis of complex diseases.  more

 
 

Stem Cells‬ for Age-related Macular Degeneration

Nature News: Japanese woman is first recipient of next-generation stem cells. Surgeons implanted retinal tissue created after reverting the patient’s own cells to ‚pluripotent‘ state.